14:00 CET

Webcast - Year-end Report 2020

Oncopeptides will also hold a webcast Thursday February 18, 2021 at 14:00 (CET) when the Year-end Report 2020 and an operational update will be presented by CEO Marty J Duvall, CMO Klaas Bakker and CFO Anders Martin-Löf.

The conference call will also be streamed via the link: https://tv.streamfabriken.com/oncopeptides-q4-2020

Phone numbers for participants from:
Sweden: +46 8 566 426 95
Europe: +44 3333 009 030
USA: +1 833 526 83 47

Upcoming events

Silent Period

-

Webcast - Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US

09:00 CET

January 21, 2022, Oncopeptides announced that the Company has contacted the US Food and Drug Administration and rescinded the October 22, 2021, letter requesting voluntary withdrawal of the NDA of Pepaxto® in the US. Investors, financial analysts and media are invited to participate in a webcast with a Q&A session on January 24, 2022, at 09:00 (CET).

Year-end report 2021

08:00 CET

Silent Period

-

Silent Period

-